ANTITUMORZUSAMMENSETZUNG

Patent europeic · EP3822355 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3822355
Numer da la dumonda
EP19833073
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
10-07-2019
Publitgà
19-05-2021
Concedì
20-05-2026
La protecziun finescha il pli tard
09-07-2039
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C12N 15/86 (2006.01)
C12N 15/113 (2010.01)
C07K 14/54 (2006.01)
A61K 38/00 (2006.01)
A61K 48/00 (2006.01)
A61P 35/00 (2006.01)
C07K 14/71 (2006.01)
A61K 35/761 (2015.01)
Prioritad
KR 20180079752 10.07.2018
Dumonda PCT
PCT/KR2019/008514 10.07.2019
Publicaziun PCT
WO2020/013617 16.01.2020
Lingua da l’annunzia
corean
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-07-2026

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 01.07.2026

  3. 20-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.05.2026

Partidas

Possessur

Genemedicine Co., Ltd.

(Fusion Technology Center-Room, Sageun-dong) 707Ho, 7th Floor, 222, Wangsimni-ro Seongdong-gu, Seoul 04763, KR

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

YUN, Chae Ok

Seoul 06583, KR

OH, Eon Ju

Seoul 04761, KR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.